DevaCell Patents – Insights & Stats (Updated 2023)

DevaCell has a total of 10 patents globally, out of which 3 have been granted. Of these 10 patents, more than 50% patents are active. The USA & Europe (EPO) is where DevaCell has filed the maximum number of patents. Parallelly, the United States seems to be the main focused R&D center of DevaCell and is also the origin country of the firm.

DevaCell was founded in the year 2015. Company is a biotechnology firm that offers therapeutic indications.

Do read about some of the most popular patents of DevaCell which have been covered by us in this article and also you can find DevaCell patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over DevaCell patent portfolio.

How many patents does DevaCell have?

DevaCell has a total of 10 patents globally. These patents belong to 2 unique patent families. Out of 10 patents, 5 patents are active.

How Many Patents did DevaCell File Every Year?

The company has 10 patents and correspondingly the filing year is 2014 and 2021.

Year of Patents Filing or GrantDevaCell Applications FiledDevaCell Patents Granted
2022
20215
20202
20191
2018
2017
2016
2015
20145

How many DevaCell patents are Alive/Dead?

Worldwide Patents

DevaCell Patent Portfolio

How Many Patents did DevaCell File in Different Countries?

DevaCell Worldwide Patent Filing

Countries in which DevaCell Filed Patents

CountryPatents
United States Of America2
Europe2
Austria1
Germany1

Where are Research Centres of DevaCell Patents Located?

The R&D Centre of patents filed by DevaCell is in the US.

List of DevaCell Patents

DevaCell PatentsTitle
US10300152B2Enzyme-Encapsulated Nanoparticle Platform
US20230272420A1Recombinant Viruses, Surface-Engineered Delivery Systems And Related Methods
EP3046550B1Enzyme-Encapsulated Nanoparticle Platform
EP4161545A2Recombinant Viruses, Surface-Engineered Delivery Systems And Related Methods
DE602014063899T2Enzyme Encapsulated Nanoparticle Platform
WO2022109503A1Recombinant Oncolytic Viruses, Surface-Engineered Delivery Systems And Related Methods
WO2022076756A1Recombinant Viruses, Surface-Engineered Delivery Systems And Related Methods
WO2021248080A3Recombinant Viruses, Surface-Engineered Delivery Systems And Related Methods
WO2015042204A1Enzyme-Encapsulated Nanoparticle Platform
AT1256466TEnzyme Encapsulated Nanoparticle Platform

What are DevaCell’s key innovation segments?

What Technologies are Covered by DevaCell?

The chart below distributes patents filed by DevaCell in different countries on the basis of the technology protected in patents. It also represents the markets where DevaCell thinks it’s important to protect particular technology inventions.

R&D Focus: How has DevaCell’s search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by DevaCell?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.